National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 1/6/2009     First Published: 5/23/2003  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
Study of Attitudes Toward the Risk of Infertility Related to Adjuvant Therapy in Women With Early Breast Cancer

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outcomes
Outline
Published Results
Trial Contact Information
Registry Information

Alternate Title

Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Educational/Counseling/Training


Active


35 and under at diagnosis


Other


EORTC-10002
BIG-3-98, NCT00062400

Objectives

  1. Determine the attitude toward the risk of infertility related to adjuvant therapy in women with early breast cancer.
  2. Correlate, if possible, the patient's attitude with the fact that the patient already has children or the time interval between the date of breast cancer diagnosis and the date of study participation.

Entry Criteria

Disease Characteristics:

  • Histologically or cytologically confirmed prior or current diagnosis of breast cancer
    • Stage I or II
    • No relapsed disease


  • No evidence of infertility
    • Regular menses or regular hormonal contraception use for the past 3 months


  • Hormonal status:
    • Not specified


Prior/Concurrent Therapy:

Biologic therapy

  • Not specified

Chemotherapy

  • Not specified

Endocrine therapy

  • See Disease Characteristics

Radiotherapy

  • Not specified

Surgery

  • Not specified

Patient Characteristics:

Age

  • 35 and under at diagnosis

Sex

  • Female

Menopausal status

  • Premenopausal

Performance status

  • Not specified

Life expectancy

  • Not specified

Hematopoietic

  • Not specified

Hepatic

  • Not specified

Renal

  • Not specified

Other

  • No psychological, familial, sociological, or geographical condition that would preclude study compliance

Expected Enrollment

385

A total of 385 patients will be accrued for this study.

Outcomes

Primary Outcome(s)

Patients who would agree to have chemotherapy if it reduces their chances of having children as assessed by questionnaire

Outline

This is a multicenter study.

Patients complete a questionnaire administered by a nontreating physician.

Published Results

Neskovic-Konstantinovic Z, Gomez H, Senkus-Konefka E, et al.: A Breast International Group survey of young breast cancer patients attitudes towards the risk of loss of fertility related to adjuvant therapies: EORTC protocol 10002 — BIG 3-98. [Abstract] 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008, San Antonio, Texas. A-3106, 2008.

Trial Contact Information

Trial Lead Organizations

European Organization for Research and Treatment of Cancer

Angelo Di Leo, MD, Study coordinator
Ph: 39-0574-43-4766
Email: adileo@usl4.toscana.it

Trial Sites

Belgium
  Brussels
 Centre Hospitalier Etterbeek Ixelles
 Contact Person
Ph: 32-641-4111
 Institut Jules Bordet
 Contact Person
Ph: 32-2-541-3181
  Liege
 CHU Liege - Domaine Universitaire du Sart Tilman
 Contact Person
Ph: 32-4-366-7111
  Wilrijk
 Algemeen Ziekenhuis Sint-Augustinus
 Contact Person
Ph: 32-3-443-37-37
Chile
  Santiago
 Clinica Alemana
 Contact Person
 Hospital Militar
 Contact Person
 Instituto de Radiomedicina
 Contact Person
Ph: 56-2-754-1700
Croatia
  Zagreb
 University Hospital Rebro
 Contact Person
Ph: 385-1-238-8644
Germany
  Frankfurt
 Klinikum der J.W. Goethe Universitaet
 Contact Person
Ph: 49-69-6301-5744
  Heidelberg
 Universitatsklinikum Heidelberg
 Contact Person
Ph: 49-6221-56-7029
Italy
  Aviano
 Centro di Riferimento Oncologico - Aviano
 Contact Person
Ph: 39-0434-659-111
  Cremona
 Azienda Istituti Ospitalieri
 Contact Person
Ph: 372-405111
  Lecco
 Ospedale Alessandro Manzoni
 Contact Person
  Milan
 European Institute of Oncology
 Contact Person
Ph: 39-02-5748-9861
Lebanon
  Beirut
 American University of Beirut Medical Center
 Contact Person
Ph: 961-1-350-000
Netherlands
  Amsterdam
 Academisch Medisch Centrum at University of Amsterdam
 Contact Person
Ph: 31-20-566-9111
  Arnhem
 Arnhems Radiotherapeutisch Instituut
 Contact Person
Ph: 31-26-371-2412
Peru
  Lima
 Instituto Nacional de Enfermedades Neoplasicas
 Contact Person
Ph: 51-1-612-9700
Poland
  Gdansk
 Medical University of Gdansk
 Contact Person
Ph: 48-58-349-2000
Portugal
  Lisboa
 Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
 Contact Person
Ph: 351-21-722-9800
Republic of South Africa
  Cape Town
 Groote Schuur Hospital
 Contact Person
Ph: 27-21-404-4265
Serbia
  Belgrade
 Institute of Oncology and Radiology of Serbia
 Contact Person
Ph: 381-361-4660
Switzerland
  Bern
 Inselspital Bern
 Contact Person
Ph: 41-31-632-2243
  Mendrisio
 Ospedale Beata Vergine
 Contact Person
Ph: 41-91-646-0101
  St. Gallen
 Kantonsspital - St. Gallen
 Contact Person
Ph: 41-71-494-1062
Turkey
  Istanbul
 Marmara University Hospital
 Contact Person
Ph: 90-327-5050
United Kingdom
Scotland
  Glasgow
 Western Infirmary
 Contact Person
Ph: 44-141-211-2000

Registry Information
Official Title A Survey of the Breast International Group (B.I.G.) to Assess the Attitude of Patients Aged Less Than 35 Years, with Early Breast Cancer, Toward the Risk of Loss of Fertility Related to Adjuvant Therapies
Trial Start Date 2003-05-05
Trial Completion Date 2008-03-31 (estimated)
Registered in ClinicalTrials.gov NCT00062400
Date Submitted to PDQ 2003-05-07
Information Last Verified 2008-04-13

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov